nebulizers and vaporizers

Summary

Summary: Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments.

Top Publications

  1. ncbi Special problems in aerosol delivery: artificial airways
    R Dhand
    Division of Pulmonary and Critical Care Medicine, Loyola University of Chicago Stritch School of Medicine, and Hines Veterans Affairs Hospital, Illinois 60141, USA
    Respir Care 45:636-45. 2000
  2. ncbi Preliminary data from phase II studies with Respimat, a propellant-free soft mist inhaler
    D Pavia
    Medical Division, Boehringer Ingelheim, Ltd, Bracknell, Berkshire, UK
    J Aerosol Med 12:S33-9. 1999
  3. ncbi Comparison of two methods of delivering continuously nebulized albuterol
    H William Kelly
    Department of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, NM 87131 5311, USA
    Ann Pharmacother 37:23-6. 2003
  4. ncbi A reappraisal of the clinical efficacy of nebulized flunisolide in pediatric asthma: the Italian experience
    Ahmad Kantar
    Istituto Pio XII, Centro per la Cura e la Riabilitazione dell Asma Infantile, Misurina, Italy
    Allergy Asthma Proc 28:671-87. 2007
  5. ncbi Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care
    M Molimard
    Departement de Pharmacologie, CHU Pellegrin Carreire, 33076 Bordeaux Cedex, France
    J Aerosol Med 16:249-54. 2003
  6. ncbi Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial
    Rudolf A Baumgartner
    Sepracor Inc, Marlborough, Massachusetts 01752, USA
    Clin Ther 29:261-78. 2007
  7. ncbi A survey of albuterol administration practices in intubated patients in the neonatal intensive care unit
    Julie Ballard
    Respiratory Care Department, Primary Children s Medical Center, 100 North Medical Drive, Salt Lake City UT 84113 1100, USA
    Respir Care 47:31-8. 2002
  8. ncbi Nebulization of a suspension of budesonide and a solution of terbutaline into a neonatal ventilator circuit
    M Turpeinen
    Department of Allergic Diseases, Helsinki University Hospital, Meilahdentie 2, FIN 00250 Helsinki, Finland
    Respir Care 46:43-8. 2001
  9. ncbi Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears!
    I Amirav
    Pediatric Department, Sieff Hospital, Safed, Israel
    Arch Dis Child 88:719-23. 2003
  10. ncbi Counseling about turbuhaler technique: needs assessment and effective strategies for community pharmacists
    Iman A Basheti
    Faculty of Pharmacy, University of Sydney, NSW 2006, Australia
    Respir Care 50:617-23. 2005

Detail Information

Publications240 found, 100 shown here

  1. ncbi Special problems in aerosol delivery: artificial airways
    R Dhand
    Division of Pulmonary and Critical Care Medicine, Loyola University of Chicago Stritch School of Medicine, and Hines Veterans Affairs Hospital, Illinois 60141, USA
    Respir Care 45:636-45. 2000
    ..3), and helium-oxygen mixture instead of air or oxygen are other measures to reduce aerosol loss in the airway and thereby improve aerosol delivery to the lower respiratory tract of mechanically ventilated patients...
  2. ncbi Preliminary data from phase II studies with Respimat, a propellant-free soft mist inhaler
    D Pavia
    Medical Division, Boehringer Ingelheim, Ltd, Bracknell, Berkshire, UK
    J Aerosol Med 12:S33-9. 1999
    ..Thus, Respimat promises to be a valuable alternative to conventional CFC-MDIs, with the additional benefit of improved drug targeting to the lungs...
  3. ncbi Comparison of two methods of delivering continuously nebulized albuterol
    H William Kelly
    Department of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, NM 87131 5311, USA
    Ann Pharmacother 37:23-6. 2003
    ..To compare the relative delivery of 2 methods for providing continuously nebulized albuterol (CNA): a small-volume nebulizer plus infusion pump versus a large-volume nebulizer...
  4. ncbi A reappraisal of the clinical efficacy of nebulized flunisolide in pediatric asthma: the Italian experience
    Ahmad Kantar
    Istituto Pio XII, Centro per la Cura e la Riabilitazione dell Asma Infantile, Misurina, Italy
    Allergy Asthma Proc 28:671-87. 2007
    ..Clinical data indicate that nebulized FLU is effective in asthma treatment in infants and children. Side effects were not reported at the commonly used doses...
  5. ncbi Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care
    M Molimard
    Departement de Pharmacologie, CHU Pellegrin Carreire, 33076 Bordeaux Cedex, France
    J Aerosol Med 16:249-54. 2003
    ..There is a need for continued education of prescribers and users in the proper use of these devices to improve treatment efficacy...
  6. ncbi Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial
    Rudolf A Baumgartner
    Sepracor Inc, Marlborough, Massachusetts 01752, USA
    Clin Ther 29:261-78. 2007
    ....
  7. ncbi A survey of albuterol administration practices in intubated patients in the neonatal intensive care unit
    Julie Ballard
    Respiratory Care Department, Primary Children s Medical Center, 100 North Medical Drive, Salt Lake City UT 84113 1100, USA
    Respir Care 47:31-8. 2002
    ....
  8. ncbi Nebulization of a suspension of budesonide and a solution of terbutaline into a neonatal ventilator circuit
    M Turpeinen
    Department of Allergic Diseases, Helsinki University Hospital, Meilahdentie 2, FIN 00250 Helsinki, Finland
    Respir Care 46:43-8. 2001
    ..Budesonide suspension (1 mg) was used in a concentration of 0.5 mg/mL and terbutaline solution (5 mg) in a concentration of 2.5 mg/mL...
  9. ncbi Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears!
    I Amirav
    Pediatric Department, Sieff Hospital, Safed, Israel
    Arch Dis Child 88:719-23. 2003
    ..Small volume nebulisers (SVNs) with masks commonly provide aerosol therapy for infants with lung diseases. However, infants and toddlers are often disturbed by and thus reject masks...
  10. ncbi Counseling about turbuhaler technique: needs assessment and effective strategies for community pharmacists
    Iman A Basheti
    Faculty of Pharmacy, University of Sydney, NSW 2006, Australia
    Respir Care 50:617-23. 2005
    ....
  11. ncbi Aerosolized PGE1: a selective pulmonary vasodilator in neonatal hypoxemic respiratory failure results of a Phase I/II open label clinical trial
    Beena G Sood
    Department of Pediatrics, Wayne State University, Children s Hospital of Michigan, 3901 Beaubien Boulevard, Detroit, MI 48201 USA
    Pediatr Res 56:579-85. 2004
    ..The results of our study indicate that IPGE(1) may be a safe, selective pulmonary vasodilator in neonatal hypoxemic respiratory failure...
  12. ncbi Repeated instruction on inhalation technique improves adherence to the therapeutic regimen in asthma
    Masaya Takemura
    Division of Respiratory Medicine, Kitano Hospital, Tazuke Kofukai, Medical Research Institute, Osaka, Japan
    J Asthma 47:202-8. 2010
    ..The objective of this study was to assess the factors and mechanisms that contribute to and the clinical outcomes relating to adherence to inhalation therapy...
  13. ncbi Evaluation of pulsed and breath-synchronized nebulization of budesonide as a means of reducing nebulizer wastage of drug
    K Nikander
    AstraZeneca R and D Lund, Lund, Sweden, and Department of Clinical Physiology, Malmo General Hospital, Malmo, Sweden
    Pediatr Pulmonol 29:120-6. 2000
    ..05). The results support the use of breath-synchronized but not pulsed nebulization with conventional nebulizers. The results of pulsed nebulization in children warrants further clinical studies...
  14. ncbi Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation
    Arzu Ari
    Division of Respiratory Therapy, School of Health Professions, Georgia State University, PO Box 4019, Atlanta GA 30302 4019, USA
    Respir Care 55:845-51. 2010
    ..The impact of nebulizer type, position on the ventilator circuit, and bias flow on aerosol drug delivery has not been established for different age populations...
  15. ncbi Aerosol delivery devices in the treatment of asthma
    Dean R Hess
    Department of Respiratory Care, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA
    Respir Care 53:699-723; discussion 723-5. 2008
    ..However, many patients use these devices incorrectly, so proper patient education in their use is critical...
  16. ncbi Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability
    V Giraud
    , Service de Pneumologie, Hĵpital A. Par, Boulogne, France
    Eur Respir J 19:246-51. 2002
    ..The use of devices which alleviate coordination problems should be reinforced in pressurized metered-dose inhaler misusers...
  17. ncbi The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team
    G K Crompton
    Respiratory Unit, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, Scotland, UK
    Respir Med 100:1479-94. 2006
    ..There is also a need for standardisation of prescribing practices throughout Europe. Regular checking of inhalation technique by prescribers is crucial as correct inhalation is one of the keystones of successful asthma management...
  18. ncbi Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease
    Malcolm Campbell
    University of Glasgow, Glasgow, UK
    Respir Med 99:1511-20. 2005
    ..Both formoterol regimens were well tolerated with no differences in adverse events or electrocardiogram profiles...
  19. ncbi Inspiratory flow rates at different levels of resistance in elderly COPD patients
    W Janssens
    Respiratory Division, University Hospital Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
    Eur Respir J 31:78-83. 2008
    ....
  20. ncbi Tiotropium HandiHaler in the treatment of COPD: a safety review
    Steven Kesten
    Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT 06877 0368, USA
    Int J Chron Obstruct Pulmon Dis 4:397-409. 2009
    ..We sought to update an evaluation of the safety of tiotropium in the HandiHaler formulation as significant clinical trial data have become available over time...
  21. ncbi Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?
    Raid A M Al-Showair
    School of Pharmacy, Institute of Pharmaceutical Innovation, University of Bradford, Bradford BD7 1DP, UK
    Respir Med 101:2395-401. 2007
    ..Some COPD patients have problems achieving required PIFs through DPIs but training is useful to help some exceed the minimum required rate despite only small improvements. The patients found it easier to slow their PIF through the MDI...
  22. ncbi Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates
    H Chrystyn
    School of Pharmacy, University of Bradford, Bradford BD7 1DP, U K
    Respir Med 97:181-7. 2003
    ..This meter can be used to identify the most suitable inhaler for each individual...
  23. ncbi In-vitro intra- and inter-inhaler flow rate-dependent dosage emission from a combination of budesonide and eformoterol in a dry powder inhaler
    W Tarsin
    School of Pharmacy, University of Bradford, Bradford BD7 1DP, United Kingdom
    J Aerosol Med 17:25-32. 2004
    ..The clinical significance of the in vitro dose-dependent properties should be investigated...
  24. ncbi Comparison of two budesonide dry powder inhalers in the treatment of asthma in children
    T Vanto
    Department of Pediatrics, Turku University Hospital, Turku, Finland
    J Aerosol Med 17:15-24. 2004
    ..Budesonide inhaled from Turbuhaler showed slightly greater systemic effects than budesonide inhaled from Easyhaler. The majority of children and parents preferred Easyhaler to Turbuhaler...
  25. ncbi Scientific rationale for using a single inhaler for asthma control
    P J Barnes
    Section of Airway Disease, National Heart and Lung Institute, Imperial College, Dovehouse St, London SW3 6LY, UK
    Eur Respir J 29:587-95. 2007
    ..There is now a strong scientific rationale for single inhaler therapy in asthma, but more research is now needed to better understand the mechanisms involved...
  26. ncbi Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial
    Michael Silverman
    Department of Infection, Inflammation and Immunology, University of Leicester, Leicester, UK
    Pediatr Allergy Immunol 17:14-20. 2006
    ..In conclusion, the addition of once-daily inhaled budesonide 200 microg via Turbuhaler to usual care is safe and well tolerated in children with recent-onset mild persistent asthma...
  27. ncbi A randomized trial of nebulized epinephrine vs albuterol in the emergency department treatment of bronchiolitis
    Colette C Mull
    Division of Emergency Medicine, Alfred I duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19899, USA
    Arch Pediatr Adolesc Med 158:113-8. 2004
    ..To determine if nebulized epinephrine is more efficacious than nebulized albuterol in the emergency department (ED) treatment of moderately ill infants with bronchiolitis...
  28. ncbi Importance of inhaler devices in the management of airway disease
    J C Virchow
    Department of Pneumology, University Medical Clinic, University of Rostock, Rostock, Germany
    Respir Med 102:10-9. 2008
    ..New and advanced devices are considered being helpful to minimise the most important problems patients have with current DPIs...
  29. ncbi Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: Archival calibration
    Virgil A Marple
    Mechanical Engineering Department, University of Minnesota, Minneapolis, MN, USA
    J Aerosol Med 16:301-24. 2003
    ..The calibration data were then used to develop equations that predict the particle cut size for all components of the impactor at any flow rate from 30 to 100 L/min...
  30. ncbi Assessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instruction
    R Dahl
    Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark
    Respir Med 97:1126-33. 2003
    ..In summary, use of the HandiHaler can be easily taught with fewer errors compared to the MDI. Furthermore, patient performance using the HandiHaler was superior to that with an MDI despite prior MDI experience and more frequent usage...
  31. ncbi A randomized, controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis
    Hema Patel
    Department of Pediatrics, McGill University Health Centre, Montreal, Quebec, Canada
    J Pediatr 141:818-24. 2002
    ..In previously well infants hospitalized with acute viral bronchiolitis, the effectiveness of repeated nebulized therapy with epinephrine (EPI) was compared with treatment with albuterol (ALB) or saline placebo (PLAC)...
  32. ncbi Determination of nebulizer droplet size distribution: a method based on impactor refrigeration
    Elna Berg
    Analytical Development, AstraZeneca R and D, Scheelevagen 2, Lund S 221 87, Sweden
    J Aerosol Med 20:97-104. 2007
    ..The method was shown to be robust, accurate with recovery of test solutions exceeding 99%, reproducible, and to be suitable for use with a wide range of commercially available nebulizers...
  33. ncbi Adjustable and fixed dosing with budesonide/ formoterol via a single inhaler in asthma patients: the ASSURE study
    P W Ind
    Respiratory Medicine, Clinical Investigation Unit, National Heart and Lung Institute, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
    Respir Med 98:464-75. 2004
    ..Consistent with current guidelines, adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma control at reduced medication doses...
  34. ncbi Basic techniques for aerosol delivery during mechanical ventilation
    Rajiv Dhand
    Division of Pulmonary, Critical Care, and Environmental Medicine, MA 421 Health Sciences Center DC043 00, 1 Hospital Drive, University of Missouri Columbia, Columbia, MO 65212, USA
    Respir Care 49:611-22. 2004
    ..The ability to efficiently deliver aerosols should lead to wider clinical application of inhaled therapies in patients receiving mechanical ventilation...
  35. ncbi Use of the next generation pharmaceutical impactor for particle size distribution measurements of live viral aerosol vaccines
    Kitty Leung
    Division of Respiratory Medicine, Hospital for Sick Children, University of Toronto, Ontario, Canada
    J Aerosol Med 18:414-26. 2005
    ..This is likely clumping of the virus due to gelatin in the formulation. These data indicate that the NGI is capable of particle sizing live biological agents...
  36. ncbi Relationship of stage mensuration data to the performance of new and used cascade impactors
    Daryl L Roberts
    MSP Corp, 5910 Rice Creek Parkway, Ste 300, Shoreview, Minnesota 55126, USA
    J Aerosol Med 18:396-413. 2005
    ..We also apply the equations to a specific mensurated impactor to show that a used impactor with some nozzles outside of the original manufacturing specifications can have the same aerodynamic performance as a new impactor...
  37. ncbi Supercritical assisted atomization: a novel technology for microparticles preparation of an asthma-controlling drug
    Giovanna Della Porta
    Dipartimento di Ingegneria Chimica e Alimentare, Universita di Salerno, Via Ponte Don Melillo, 84084 Fisciano, SA, Italy
    AAPS PharmSciTech 6:E421-8. 2005
    ..0 microm was calculated for the jet-milled drug. SAA samples also exhibited narrower particle size distribution (PSD). A good control of particle size and distribution together with no drug degradation was obtained by SAA process...
  38. ncbi Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients
    Rajiv Dhand
    Division of Pulmonary, Critical Care, and Environmental Medicine, Department of Internal Medicine, University of Missouri Columbia, 65212, USA
    Respir Care 50:1331-4; discussion 1344-5. 2005
    ..In mechanically ventilated patients, pMDIs are a cost-effective, convenient, and safe method for delivering bronchodilator aerosols...
  39. ncbi An in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditions
    Lars Borgström
    AstraZeneca R and D, Lund, Sweden
    J Aerosol Med 18:304-10. 2005
    ..The clinical importance of this finding has not been studied but could result in undertreatment...
  40. ncbi Randomized, placebo-controlled trial of albuterol and epinephrine at equipotent beta-2 agonist doses in acute bronchiolitis
    Shawn Ralston
    Department of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
    Pediatr Pulmonol 40:292-9. 2005
    ....
  41. ncbi Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat soft mist inhaler
    Rick Hodder
    Department of Critical Care, University of Ottawa, Ottawa, Ontario, Canada
    Respir Med 99:1087-95. 2005
    ..There was no increase in the incidence of events during 12 weeks' treatment. Delivery of bronchodilators by Respimat SMI is safe with regard to paradoxical bronchoconstriction during chronic use in patients with asthma or COPD...
  42. ncbi Development and validation of a patient satisfaction and preference questionnaire for inhalation devices
    Chris M Kozma
    College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA
    Treat Respir Med 4:41-52. 2005
    ..Furthermore, a difference in satisfaction scores between treatment groups of 10 points is, conservatively, a difference that is meaningful to patients...
  43. ncbi Survey of pharmacists' attitudes towards interchangeable use of dry powder inhalers
    Angela E Williams
    GlaxoSmithKline, Greenford Road, Greenford, Middlesex, UK
    Pharm World Sci 29:221-7. 2007
    ..Patients dispensed an unfamiliar device in which they have received no training, risk poor inhalation technique with the potential for inadequate dosing and loss of disease control...
  44. ncbi Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery systems: an in vitro study
    Robert E Van Dyke
    CoTherix, 2000 Sierra Point Parkway, Suite 600, South San Francisco, CA 94005, USA
    Respir Care 52:184-90. 2007
    ..The HaloLite device was the first-generation AAD system used in the clinical delivery of inhaled iloprost, and I-neb is the third-generation system...
  45. ncbi Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma
    R Scicchitano
    Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, SA, Australia
    Curr Med Res Opin 20:1403-18. 2004
    ....
  46. ncbi Effect of particle morphology on the triboelectrification in dry powder inhalers
    Matti Murtomaa
    Department of Physics, University of Turku, FIN 20014 Turku, Finland
    Int J Pharm 282:107-14. 2004
    ....
  47. ncbi Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics
    Walid Y Tarsin
    School of Pharmacy and Institute of Pharmaceutical Innovation, University of Bradford, Bradford BD7 1DP, United Kingdom
    Int J Pharm 316:131-7. 2006
    ..The results highlight a more significant effect of inspiratory flow on variable dosage emission when using the Symbicort Turbuhaler compared with the Seretide Diskus...
  48. ncbi Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers
    Michael J Welch
    Allergy and Asthma Medical Group and Research Center, San Diego, California 92123, USA
    J Aerosol Med 17:129-39. 2004
    ..05). Overall, patients preferred Pulmicort Turbuhaler over pMDIs and required less time to be taught how to correctly use Turbuhaler trade mark...
  49. ncbi A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease
    Frank Kässner
    Pneumologisches Zentrum Cottbus, Grobeta Gaglow, Germany
    Drugs 64:1671-82. 2004
    ..In children, Respimat SMI obviates the need for a spacer...
  50. ncbi Meeting the needs of patients with COPD: patients' preference for the Diskus inhaler compared with the Handihaler
    A C Moore
    GlaxoSmithKline Research and Development Ltd, Greenford, Middlesex, UK
    Int J Clin Pract 58:444-50. 2004
    ..The Diskus was rated higher than the Handihaler for the top three features of an ideal inhaler. Overall the Diskus inhaler was preferred by 67% of patients...
  51. ncbi Analysis of cascade impactor mass distributions
    Craig Dunbar
    Alkermes, Inc, 88 Sidney St, Cambridge, Massachusetts 02139, USA
    J Aerosol Med 18:439-51. 2005
    ....
  52. ncbi The importance of the device in asthma therapy
    L Borgstrom
    AstraZeneca R and D, Lund, Sweden
    Respir Med 95:S26-9. 2001
    ..Thus, the development of Turbuhaler represents an important step forward in the effective management of asthma...
  53. ncbi In vitro/in vivo comparisons in pulmonary drug delivery
    Stephen P Newman
    J Aerosol Med Pulm Drug Deliv 21:77-84. 2008
    ..At the present time there are few published data that relate APSD to the clinical response of inhaled drugs in an unambiguous way...
  54. ncbi Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study
    P M van Grunsven
    Department of Family Practice and Social Medicine, University of Nijmegen, The Netherlands
    J Asthma 37:225-34. 2000
    ..These results again emphasize the importance of patient education in establishing early treatment with inhaled corticosteroids...
  55. ncbi Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling technique
    Simon Warren
    Cardiff Scintigraphics Limited, Cardiff, United Kingdom
    J Aerosol Med 15:15-25. 2002
    ..These results indicate that, in healthy volunteers, budesonide lung deposition was higher and more consistent with the Clickhaler than with the Turbuhaler...
  56. ncbi Compliance from self-reported versus pharmacy claims data with metered-dose inhalers
    S R Erickson
    College of Pharmacy, University of Michigan, Ann Arbor, MI 48109 1065, USA
    Ann Pharmacother 35:997-1003. 2001
    ..To determine how well self-reported compliance with metered-dose inhalers (MDIs) agrees with compliance determined from pharmacy claims data. Additional analyses were conducted to establish phychmetric properties of the questionnaire...
  57. ncbi Effect of drug load and plate coating on the particle size distribution of a commercial albuterol metered dose inhaler (MDI) determined using the Andersen and Marple-Miller cascade impactors
    M M Nasr
    US Food and Drug Administration, CDER, Division of Testing and Applied Analytical Development DTAAD, St Louis, Missouri 63101, USA
    Pharm Res 14:1437-43. 1997
    ..The results of the investigation will be used to explain the "loading effect" recently reported...
  58. ncbi Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care
    W Summer
    Department of Medicine, Lousisiana State University Medical School, New Orleans 70112
    Arch Intern Med 149:618-23. 1989
    ..In hospitalized bronchodilator-responsive patients with acute exacerbations of obstructive airway disease, the MDI/spacer combination is the preferred approach when the status of the patient allows its use...
  59. ncbi Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity
    S Chodosh
    Veterans Administration Outpatient Clinic, Pulmonary Research, Boston, Massachusetts, USA
    J Aerosol Med 14:309-15. 2001
    ..The minimum peak inspiratory flow rates in the three groups were 28.2, 21.6 and 20.4 L/min. The HandiHaler device effectively delivers particles to the lung over a wide range of airflow limitation in patients with COPD...
  60. ncbi Efficacy of salbutamol via Easyhaler unaffected by low inspiratory flow
    T Koskela
    Orion Pharma, Easyhaler Project, Kuopio, Finland
    Respir Med 94:1229-33. 2000
    ..Hence, Easyhaler can be used with confidence in patients who may have difficulty in generating a high inspiratory flow rate, such as children and the elderly...
  61. ncbi Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis
    P Bertrand
    Department of Pediatrics, School of Medicine, Catholic University of Chile, Santiago, Chile
    Pediatr Pulmonol 31:284-8. 2001
    ..03 vs. P = 0.025). No adverse effects were associated with nebulized therapy. We conclude that nebulized epinephrine is a more effective agent than salbutamol in the initial treatment of bronchiolitis and is equally safe...
  62. ncbi The influence of lung deposition on clinical response
    J N Pritchard
    Glaxo Wellcome, Uxbridge, Middlesex, United Kingdom
    J Aerosol Med 14:S19-26. 2001
    ..Current devices have profoundly different lung deposition profiles that could affect clinical efficacy when switching devices. Devices that achieve a high lung to systemic ratio for the inhaled drug are preferable...
  63. ncbi The efficacy of nebulized metaproterenol in wheezing infants and young children
    A J Alario
    Department of Pediatrics, Brown University School of Medicine, Providence, RI
    Am J Dis Child 146:412-8. 1992
    ....
  64. ncbi A randomized clinical trial of nebulized magnesium sulfate in addition to albuterol in the treatment of acute mild-to-moderate asthma exacerbations in adults
    Olga Bessmertny
    Long Island University, Arnold and Marie Schwartz College of Pharmacy, Brookdale University Hospital and Medical Center, Brooklyn, NY 11212-3198, USA
    Ann Emerg Med 39:585-91. 2002
    ..The efficacy of nebulized MgSO(4) in patients with severe asthma exacerbations remains unknown...
  65. ncbi Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, p
    William Busse
    Department of Allergy and Immunology, University of Wisconsin Medical School, Madison, Wisconsin, USA
    Clin Ther 26:1587-98. 2004
    ..Formoterol was well tolerated in these patients...
  66. ncbi The cohesive-adhesive balances in dry powder inhaler formulations II: influence on fine particle delivery characteristics
    Philippe Begat
    Pharmaceutical Technology Research Group, Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, United Kingdom
    Pharm Res 21:1826-33. 2004
    ....
  67. ncbi Management of acute asthma in children using metered dose inhaler and small volume nebulizer
    Syed Waseem Jamalvi
    Department of Pediatrics, Jinnah Medical and Dental College, Karachi
    J Pak Med Assoc 56:595-9. 2006
    ..CONCLUSION: The data suggested that MDI/AD is an effective alternative to nebulizer for the treatment of children with acute asthma exacerbation in the ER...
  68. ncbi Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics
    Anthony J Hickey
    Division of Molecular Pharmaceutics, School of Pharmacy, University of North Carolina at Chapel Hill, Campus Box 7360, 1310 Kerr Hall, Chapel Hill, North Carolina 27599 7360, USA
    J Pharm Sci 96:1302-19. 2007
    ....
  69. ncbi Deposition of aerosols in infants and children
    Karen G Schüepp
    Swiss Paediatric Respiratory Research Group, Department of Respiratory Medicine, University Children s Hospital, Zurich, Switzerland
    J Aerosol Med 17:153-6. 2004
    ..The development of combinations of delivery devices and drug formulations fulfilling the requirements for an efficient inhalation therapy in young children is likely to increase the therapeutical options in this age group...
  70. ncbi Inhalatory therapy training: a priority challenge for the physician
    Andrea S Melani
    Respiratory Physiopathology and Rehabilitation, Cardiothoracic Department, Polyclinic Le Scotte, Azienda Ospedaliera Universitaria Senese, Siena, Italy
    Acta Biomed 78:233-45. 2007
    ..Whatever the chosen inhaler, education from health caregivers has a key-role for improving inhaler technique and compliance. Differences among delivery devices represent another challenge to patient use and caregiver instruction...
  71. ncbi Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects
    T W Harrison
    Respiratory Medicine, Nottingham City Hospital, Nottingham NG5 1PB, UK
    Thorax 58:258-60. 2003
    ..To provide more information on the absorption of fluticasone propionate and budesonide, we have compared the plasma levels of both drugs over 8 hours in healthy and asthmatic subjects...
  72. ncbi Spacer devices for metered dose inhalers
    Stephen P Newman
    Pharmaceutical Profiles Ltd, Ruddington, Nottingham, UK
    Clin Pharmacokinet 43:349-60. 2004
    ....
  73. ncbi [The physician-pharmacist team in the education of patients concerning inhalant therapy]
    N Le Gouldec
    , CHU Tours-37044 Tours
    Allerg Immunol (Paris) 33:383-7. 2001
    ..Such is the aim of this presentation which should not be considered as a return to the past, but an advance towards the individualized formulation of patients by benefitting from the former experiences of corporative formations...
  74. ncbi [Treatment of exacerbation of asthma: what are today's issues?]
    D Ploin
    DIM des Hospices Civils de Lyon, 162, avenue Lacassagne, 69424 Lyon cedex 03 et Réseau d Epidémiologie Clinique International Francophone RECIF, Universite Claude Bernard Lyon I, France
    Arch Pediatr 12:351-6. 2005
    ....
  75. ncbi Ventolin Diskus and Inspyril Turbuhaler: an in vitro comparison
    M E A C Broeders
    Department of Pulmonary Diseases, Dekkerswald, University of Nijmegen, Groesbeek, The Netherlands
    J Aerosol Med 18:74-82. 2005
    ..The flow dependency of TED and FPM was substantially influenced by inhalation profiles when not only profiles of the usual outpatient population were included but also the real outliers from exacerbated patients...
  76. ncbi Efficacy and safety of formoterol delivered via a new multidose dry powder inhaler (Certihaler) in adolescents and adults with persistent asthma
    C LaForce
    North Carolina Clinical Research, Raleigh, North Carolina, USA
    J Asthma 42:101-6. 2005
    ..Formoterol 10 microg BID, delivered via the novel Certihaler device, is well tolerated and provides rapid, long-lasting, and clinically superior bronchodilation to placebo and albuterol via pMDI in patients with persistent asthma...
  77. ncbi Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study
    Kevin Weiss
    Institute for Health Studies, Midwest Center for Health Services and Policy Research, Hines, VA, USA
    Pediatr Allergy Immunol 17:21-7. 2006
    ....
  78. ncbi Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial
    Klaus F Rabe
    Department of Pulmonology, C3 P, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
    Chest 129:246-56. 2006
    ..To compare a novel asthma management strategy--budesonide/formoterol in a single inhaler for both maintenance therapy and symptom relief--with a higher dose of budesonide plus as-needed terbutaline...
  79. ncbi A dry powder inhaler with reduced mouth-throat deposition
    Z L Wang
    Department of Mechanical Engineering, University of Alberta, Edmonton, Alberta, Canada
    J Aerosol Med 19:168-74. 2006
    ..0% +/- 3.5% with the present inhaler. The different lung deliveries from the same inhaler for the two formulations above also confirm that the overall performance of an inhaler is optimizable via powder formulations...
  80. ncbi Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler
    A H de Boer
    Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, A Deusinglaan 1, 9713 AV Groningen, The Netherlands
    Int J Pharm 310:72-80. 2006
    ..5 and 2 s at 60 l/min is considered favourable, as this yields a high fine particle dose (depending on the type of formulation used) and leaves sufficient inhaled volume for particle transport into the deep lung...
  81. ncbi Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler
    A H de Boer
    Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, A Deusinglaan 1, 9713 AV Groningen, The Netherlands
    Int J Pharm 310:81-9. 2006
    ..Finally, it is shown that this inhaler produces a finer aerosol than competitor devices, within the fpf<5 microm, subfractions of particles (e.g. <1, 1-2, 2-3, 3-4 and 4-5 microm) are higher...
  82. ncbi Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation
    Daniela Traini
    Advanced Drug Delivery Group, Faculty of Pharmacy (A15, University of Sydney, NSW 2006, Australia
    Eur J Pharm Sci 27:243-51. 2006
    ..05) than from lactose monohydrate, with a fine particle dose (<6.4 microm) of 41.9 +/- 7.4 microg and 24.9 +/- 3.1 microg for the lactose monohydrate and erythritol carriers, respectively (n = 3)...
  83. ncbi Paediatric pulmonary drug delivery: considerations in asthma treatment
    William E Berger
    Allergy and Asthma Associates of Southern California, Mission Viejo, CA 92691 6410, USA
    Expert Opin Drug Deliv 2:965-80. 2005
    ..Although age-based device recommendations have been made, the optimal choice for drug delivery is the one that the patient or caregiver prefers to use, can use correctly and is most likely to use consistently...
  84. ncbi Generating monodisperse pharmacological aerosols using the spinning-top aerosol generator
    Martyn F Biddiscombe
    Nuclear Medicine, Royal Brompton Hospital, and National Heart and Lung Institute, Imperial College London, London, United Kingdom
    J Aerosol Med 19:245-53. 2006
    ..The aerosols generated by the STAG can allow investigators to study the scientific principles of inhaled drug deposition and lung physiology for a range of therapeutic agents...
  85. ncbi Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses
    Anne H de Boer
    Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Ant Deusinglaan 1, 9713 AV Groningen, The Netherlands
    Eur J Pharm Sci 28:171-8. 2006
    ..The classifiers can be designed to retain these crystals with more than 95% efficiency...
  86. ncbi Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler
    Gary Pitcairn
    Pharmaceutical Profiles Ltd, Nottingham, United Kingdom
    J Aerosol Med 18:264-72. 2005
    ..The results of this study showed that Respimat SMI deposited corticosteroid more efficiently in the lungs than either of two widely used inhaler devices, Turbuhaler DPI or Becloforte pMDI...
  87. ncbi Adherence to asthma controller medication regimens
    D A Stempel
    Department of Pediatrics, Infomed Northwest and University of Washington, Bellevue, WA 98004, USA
    Respir Med 99:1263-7. 2005
    ....
  88. ncbi Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers
    Xian Ming Zeng
    King s College London, Pharmaceutical Science Research Division, Franklin Wilkins Building, 150 Stamford Street, London SE1 9NN, United Kingdom
    Int J Pharm 333:45-55. 2007
    ..LD was capable of detecting subtle differences between the various formulations and generated FPF results that correlated with those measured by MSLI...
  89. ncbi Maintenance asthma treatment with fluticasone/salmeterol combination via Diskus: effect on outcomes in inner-city children enrolled in TennCare
    William T Nguyen
    University of Tennessee and LeBonheur Children's Medical Center, 910 Madison Avenue, Memphis, TN 38163, USA
    Allergy Asthma Proc 26:129-34. 2005
    ..49-0.90; p = 0.005). Our results suggest that fluticasone/salmeterol combination via Diskus is associated with a reduction in risk of acute exacerbations of asthma in inner-city children, including ED visits and hospitalizations...
  90. ncbi Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures
    A M A Elhissi
    Department of Pharmaceutics, School of Pharmacy, University of London, 29 39 Brunswick Square, London WC1N 1AX, UK
    Int J Pharm 334:62-70. 2007
    ..On the other hand, the air-jet nebulizer produced higher total mass and drug outputs and smaller aerosol droplets...
  91. ncbi Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations
    Gary P Martin
    Pharmaceutical Science Research Division, King s College London, Franklin Wilkins Building, 150 Stamford Street, London SE1 9NH, UK
    Pharm Res 24:361-9. 2007
    ....
  92. ncbi A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler
    G Bensch
    Allergy, Immunology, and Asthma Medical Group, Stockton, California 95207, USA
    Ann Allergy Asthma Immunol 86:19-27. 2001
    ..CONCLUSIONS: Rapid-onset, long-acting formoterol, administered via the Aerolizer inhaler, is an effective and safe treatment for patients with mild to moderate persistent asthma...
  93. ncbi Effectiveness of nebulized furosemide added to nebulized salbutamol in children with acute asthma
    Cagatay Nuhoglu
    Haydarpasa Numune Training and Research Hospital, Department of Pediatrics, Istanbul, Turkey
    Allergol Immunopathol (Madr) 34:54-8. 2006
    ..Nebulized furosemide has been shown to be protective against bronchoconstricting stimuli...
  94. ncbi [Inhaled therapy via nebulization: practical issues]
    Sabina Antoniu
    Universitatea de Medicină si Farmacie Gr T Popa Iaşi
    Pneumologia 56:143-6. 2007
    ..Better knowledge of practical issues related with nebulization, which is the aim of this paper, could contribute to a more effective use of...
  95. ncbi Formoterol fumarate inhalation powder vs albuterol nebulizer for the treatment of asthma in the acute care setting
    Mary Lee-Wong
    Division of Allergy and Clinical Immunology, Department of Medicine, Beth Israel Medical Center, New York, New York 10003, USA
    Ann Allergy Asthma Immunol 100:146-52. 2008
    ..Although albuterol remains the standard treatment for asthma in the emergency department, formoterol fumarate may be more advantageous, with its rapid and long-lasting bronchodilation...
  96. ncbi [Effects of combined therapy with domestic inhalational anti-asthmatic drugs on oxidant status of patients with bronchial asthma]
    A F Kolpakova
    Ter Arkh 79:41-4. 2007
    ..CONCLUSION: Both biasten and benacort in combination with salben provide BA control, reduce severity of free radical oxidation disorders...
  97. ncbi Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionate
    Stephen B Shrewsbury
    MAP Pharmaceuticals Inc, Mountain View, CA, USA
    Int J Pharm 356:137-43. 2008
    ..Thus, the Tempo inhaler enhances efficient drug delivery to the lungs...
  98. ncbi Delivery of salbutamol and of budesonide from a novel multi-dose inhaler Airmax
    X M Zeng
    IVAX Pharmaceutical UK Ltd, Royal Docks, London
    Respir Med 96:404-11. 2002
    ..There was no change in dose content uniformity and aerodynamic particle-size distribution after the devices have been stored unwrapped at 30 degrees C/60% RH up to 24 months. Airmax is robust, portable and intuitive to use...
  99. ncbi Evaluation of an in vitro in vivo correlation for nebulizer delivery using artificial neural networks
    Marcel de Matas
    Institute of Pharmaceutical Innovation, University of Bradford, Bradford, UK
    J Pharm Sci 96:3293-303. 2007
    ..It is therefore concluded that ANN models have the potential to provide reliable estimates of pharmacokinetic performance that relate to lung deposition, for nebulized medicines in individual subjects...
  100. ncbi Novel alternative methods for the delivery of drugs for the treatment of asthma
    Hak Kim Chan
    Faculty of Pharmacy, A15, University of Sydney, Sydney NSW 2006, Australia
    Adv Drug Deliv Rev 55:793-805. 2003
    ..Each of these determinants for powder aerosol delivery is reviewed with a strong focus on the patent literature that contains enormous information about the latest development in this field...
  101. ncbi The effects of Heliox on the output and particle-size distribution of salbutamol using jet and vibrating mesh nebulizers
    Christopher O'Callaghan
    Department of Infection, Immunity and Inflammation, Division of Child Health, University of Leicester, Leicester Royal Infirmary, Leicester, United Kingdom
    J Aerosol Med 20:434-44. 2007
    ..Such information is required to allow appropriate interpretation of clinical trials of drug delivery using Heliox...

Research Grants111 found, 100 shown here

  1. Asthma Treatment with a Novel Drug Aerosol Generator
    William Shen; Fiscal Year: 2004
    ..Successful completion of activities in Phase I would present a significant step towards developing an improved inhalation drug delivery platform for asthma treatment. ..
  2. Pediatric Asthma Alert Intervention in Minority Children
    ARLENE MANNS BUTZ; Fiscal Year: 2010
    ....
  3. SUPRAER, High Dose Rate Aerosol Drug Delivery
    DONOVAN YEATES; Fiscal Year: 2007
    ..SUPRAER(tm) will decrease the time required for inhalation therapy as well as broaden the range of therapeutic agents that can be successfully administered via the respiratory tract. ..
  4. EBP Leadership Summit: Improving health outcomes for high risk children and teens
    Bernadette Melnyk; Fiscal Year: 2007
    ..S. to improve health outcomes for our nation's children and adolescents. ..
  5. MEMS-Based High-Frequency Ultrasonic Nozzles for Medical Applications
    CHEN TSAI; Fiscal Year: 2007
    ..Such new devices may ultimately be developed into efficient pocket-sized nebulizers for drug delivery by inhalation and should, therefore, have important implications for public health. ..
  6. Aerosol Therapy for Lung Cancer
    Brian Hansen; Fiscal Year: 2007
    ..The Phase II goal is to demonstrate the potential efficiency of the new drug formulations in vitro and in vivo and to develop aerosol equipment that is suitable for pre-clinical testing, clinical trials, and patient care. ..
  7. Novel Strategies Targeting Acute Exacerbation of COPD
    Richard Albert; Fiscal Year: 2007
    ..This information will, at the same time, also provide information regarding the pathobiology of COPD exacerbations. ..
  8. AuContrAer:Ventilator Compatible Aerosol Delivery Device
    Richard Parker; Fiscal Year: 2002
    ..We tentatively call the device AuContrAer. ..
  9. Targeting JAK-3 with WHI-P97 for Treatment of Asthma
    Peter Samuel; Fiscal Year: 2003
    ..The successful completion of the proposed research will provide the foundation for further translational research that may lead to new and effective methods for treatment of allergic asthma. ..
  10. Improving Asthma Communication in Minority Families
    Arlene Butz; Fiscal Year: 2007
    ..abstract_text> ..
  11. Inhalation Dosimetry/Exposure Index of Fiber Aerosol
    Yung Sung Cheng; Fiscal Year: 2006
    ..Sampling devices based on this size-selection definition can be developed in the future for improved assessment of worker exposure. ..
  12. NEBULIZER INTERVENTION IN MINORITY CHILDREN WITH ASTHMA
    Arlene Butz; Fiscal Year: 2004
    ..Study findings will improve clinical care to this vulnerable population of children and will be if significant use to health care providers, researchers, insurers and policy makers. ..
  13. A+ Asthma Rural Partnership
    Arlene Butz; Fiscal Year: 2004
    ..The findings of this study will be important to clinicians, researchers, and health policy makers. ..
  14. Development of a Highly Efficient Personal Sampler to collect Viable Bioaerosols
    Yung Sung Cheng; Fiscal Year: 2010
    ..The new device will not only be beneficial in occupational settings, but may also have future potential in high risk areas such as those following any possible biological attack. ..
  15. HOME NURSE INTERVENTION FOR IUDE INFANTS--3 YR FOLLOW UP
    Arlene Butz; Fiscal Year: 2002
    ..Data will be of significant use to researchers, health care providers, insurers and policy makers. ..
  16. Pediatric Asthma Alert Intervention in Minority Children
    Arlene Butz; Fiscal Year: 2009
    ....
  17. Development of a Highly Efficient Personal Sampler to collect Viable Bioaerosols
    Yung Sung Cheng; Fiscal Year: 2009
    ..The new device will not only be beneficial in occupational settings, but may also have future potential in high risk areas such as those following any possible biological attack. ..
  18. Development of a Personal Sampler for Nanoparticles
    Yung Sung Cheng; Fiscal Year: 2010
    ..It can be used to assess personal exposure to nanoparticles in terms of mass concentration and physicochemical characteristics. ..
  19. Aerosolized PGE1 in Neonatal Pulmonary Hypertension
    BEENA SOOD; Fiscal Year: 2005
    ..If effective, a proposal for using aerosolized PGE1 in neonatal PPHN as a multicenter study will be submitted to the NICHD Neonatal Network. ..
  20. MECHANISMS OF RESPONSE TO PULMONARY VACCINATION
    Anthony Hickey; Fiscal Year: 2005
    ..The significance of this work lies in the novelty of pulmonary vaccination for the treatment of tuberculosis and the knowledge of the immune response gained from targeted antigen delivery to the lungs. ..
  21. Response to Beta2-Agonists in Acute Severe Asthma
    Nicola Hanania; Fiscal Year: 2007
    ..abstract_text> ..
  22. NICOTINE DEPENDENCE--TAILORING AND PREFERENCE RESEARCH
    Nina Schneider; Fiscal Year: 2001
    ..Several new scales will be tested: one which assesses withdrawal via anchored responding and a set of scales for testing preference with an ultimate aim of developing a tool for easily matching smokers to therapy. ..
  23. COCAINE SMOKING EFFECTS ON LUNG IMMUNITY & HOST DEFENSE
    Donald Tashkin; Fiscal Year: 2002
    ..findings which relate to susceptibility to opportunistic infections in HIV-infected cocaine smokers. ..
  24. Ozone ALTERS Airway Smooth Muscle FUNCTION IN ASTHMA
    Reynold Panettieri; Fiscal Year: 2007
    ..These studies will identify the mechanisms by which ozone enhances allergen-induced AHR and provide insight into new therapeutic targets to prevent asthma exacerbations and decrease asthma morbidity and mortality. ..
  25. Children and Asthma: Communication and Outcomes
    Betsy Sleath; Fiscal Year: 2007
    ..abstract_text> ..
  26. Natural History of Asthma from Birth to Early Adult Life
    Fernando D Martinez; Fiscal Year: 2010
    ..Elucidating these relations will foster the development of new strategies for the prevention and treatment of asthma and, potentially, of airflow limitation in adult life. ..
  27. RGS: A Molecular Switch Regulating Irreversible ASM Growth/Contraction in Asthma
    Reynold Panettieri; Fiscal Year: 2009
    ..Our studies will identify the key mechanisms by which RGS proteins regulate ASM growth and contractility while providing insight into therapeutic targets to abrogate ASM hyperplasia and hyperresponsiveness in asthma. (End of Abstract) ..
  28. Interferons Modulate Airway Smooth Muscle Growth
    Reynold Panettieri; Fiscal Year: 2007
    ....
  29. Natural History of Asthma from Birth to Early Adult Life
    Fernando Martinez; Fiscal Year: 2009
    ..Elucidating these relations will foster the development of new strategies for the prevention and treatment of asthma and, potentially, of airflow limitation in adult life. ..
  30. Mechanisms of VEGF modulation of smooth muscle function
    Reynold Panettieri; Fiscal Year: 2009
    ..abstract_text> ..
  31. Mechanisms Regulation Functions of Airway Smooth Muscle
    Reynold Panettieri; Fiscal Year: 2007
    ..Thus, understanding the transcriptional mechanisms regulating the expression of inflammatory genes in ASM will likely lead to new therapeutic approaches for the treatment of asthma. ..
  32. Mechanisms of VEGF modulation of smooth muscle function
    Reynold Panettieri; Fiscal Year: 2007
    ....
  33. MECHANISMS REGULATING AIRWAY MUSCLE GROWTH
    Reynold Panettieri; Fiscal Year: 2003
    ..These studies will define the mechanism by which agonists induce ASM cell growth such that new issues in the pathogenesis of asthma will be addressed and therapeutic measures to prevent these alterations can be developed. ..
  34. CHROMOSOME 5Q GENE VARIANTS AND ASTHMA-RELATED TRAITS
    Fernando Martinez; Fiscal Year: 2004
    ..This will allow to better understand the genetic influence that determine asthma risk. ..
  35. LONGITUDINAL STUDY OF ASTHMA FROM BIRTH TO ADOLESCENCE
    Fernando Martinez; Fiscal Year: 2000
    ..In the evaluation at age 16 years, symptoms, lung function, including methacholine responsiveness, and atopy and lymphocyte phenotype will be assessed. Various methods for longitudinal data analysis will be employed. ..
  36. INNATE IMMUNITY IN HEART, LUNG, AND BLOOD DISEASE
    Fernando Martinez; Fiscal Year: 2003
    ..abstract_text> ..
  37. ASTHMA AND INTERVENTIONS IN THE EMERGENCY DEPARTMENT
    Robert Strunk; Fiscal Year: 2002
    ..The intent to treat model will be used, as primary outcome can be obtained after consent even if not contact cannot be made at 2 week and 6 month phone calls. ..
  38. MECHANISMS REGULATING AIRWAY MUSCLE GROWTH
    Reynold Panettieri; Fiscal Year: 1999
    ..By understanding the mechanisms of ASM cell growth, new issues in the pathogenesis of asthma will be addressed and therapeutic measures to prevent these alterations can be developed. ..
  39. THE MODULATION OF INFLAMMATORY RESPONSES IN THE LUNG
    Stephen Peters; Fiscal Year: 1993
    ..In addition, they will provide crucial information needed in order to develop novel strategies for the treatment of asthma using antiinflammatory agents...
  40. Modeling of Aerosol Transport in Alveolated Airways
    Chantal Darquenne; Fiscal Year: 2009
    ..The results of this study will provide a link to the mechanisms by which even seemingly modest PM exposure can cause or exacerbate lung disease and will also help to better design spatial targeting of inhaled drugs. ..